首页> 外文期刊>Leukemia Research Reports >A rare case of a minimally secretory plasma cell leukemia with a hemorrhagic gastric plasmacytoma
【24h】

A rare case of a minimally secretory plasma cell leukemia with a hemorrhagic gastric plasmacytoma

机译:罕见的少量分泌性浆细胞白血病伴出血性胃浆细胞瘤

获取原文
           

摘要

Plasma cell leukemia(PCL) is a rare and aggressive plasma cell neoplasm characterized by clonal plasma cells comprising more than 20% of the leukocytes in the circulation and/or an absolute clonal plasma cell count of more than 2 × 10 9 [1,2]. PCL accounts for 2–4% of plasma cell dyscrasias [3]. PCL is more common in African Americans, compared to Caucasians [3], with more male preponderance [4]. PCL arising de novo without prior evidence of multiple myeloma (MM) is termed primary PCL(PPCL), and PCL evolving from a preexisting MM is termed as secondary PCL(SPCL). According to the literature, 60–70% of PCLs are primary, and 30–40% are secondary [3,5]. The chances of refractory and relapsed MM progressing to SPCL is 1–2% [3,6]. PCL is a rare disease and the precise information regarding its incidence, clinical presentation, and pathological features are unfolding gradually [7].
机译:浆细胞白血病(PCL)是一种罕见的侵袭性浆细胞肿瘤,其特征是克隆浆细胞包含循环中超过20%的白细胞和/或绝对克隆浆细胞计数超过2×10 9 [1,2 ]。 PCL占浆细胞发育不良的2–4%[3]。与高加索人[3]相比,PCL在非裔美国人中更为常见,男性占多数[4]。在没有多发性骨髓瘤(MM)事先证据的情况下从头产生的PCL被称为原发性PCL(PPCL),而从先前存在的MM演变而来的PCL被称为继发性PCL(SPCL)。根据文献,60%到70%的PCL是原发性的,而30%到40%的是继发性的[3,5]。难治性和复发性MM进展为SPCL的机会为1-2%[3,6]。 PCL是一种罕见的疾病,有关其发生率,临床表现和病理特征的确切信息正在逐步展现[7]。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号